Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from IR-Med ( (IRME) ).
On September 16, 2025, IR-Med, Inc. completed a private placement offering, issuing 1,562,500 shares of common stock and warrants to purchase an additional 781,250 shares, raising $25,000 in gross proceeds. The company’s CEO, Ran Ziskind, was a significant participant, purchasing 937,500 shares and 468,750 warrants. The securities were exempt from registration under the Securities Act, highlighting the company’s strategic move to secure investment while maintaining compliance with regulatory requirements.
More about IR-Med
Average Trading Volume: 166,689
Technical Sentiment Signal: Strong Sell
Current Market Cap: $3.52M
For detailed information about IRME stock, go to TipRanks’ Stock Analysis page.